Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vestas and Danish Export Credit Agency unlock Vietnamese wind energy project through innovative financing structure that can be used in other emerging markets

News release from Vestas Asia PacificSingapore, 13 March 2019With emerging markets looking to renewable energy to fuel their growth, securing competitive financing solutions play a key role in ensuring projects achieve attractive financial returns. With challenges associated with project bankability, the cost of local lending, and risk allocation, innovative financial solutions are a key enabler to unlock projects and drive further renewable energy development around the globe. Recently, Vestas’ Structured Finance function demonstrated its ability to provide customised renewable

Cloetta´s Annual report 2018 available on the website

Cloetta´s annual report 2018 has today been published on Cloetta´s website.The annual report, which also includes the sustainability report, can be downloaded at www.cloetta.com/annualreport2018  The financial year covers the period from 1 January to 31 December 2018. This information is information that Cloetta AB (publ) is required to disclose pursuant to the Securities Markets Act. The information was submitted, by the below

Primary insider assignment of remuneration shares

Primary insider Erik Ranberg has been allocated 864 shares as variable pay for 2018. His total number of shares not redeemed (remuneration and share savings scheme) is 2609 and his shareholding (including closely related parties) is 12 256. For a description of the share-based remuneration scheme for executive personnel, please see note 22 in the 2018 annual report. This information is subject to disclosure under the Norwegian Securities Act section §5-12. Contacts: Head of Investor Relations, Mitra Hagen Negård, Tel +47 957 93 631 Head of Communication, Øystein Thoresen, Tel:

Double Bond Pharma signed a distribution agreement with Euroresearch Srl

Double Bond Pharmaceutical (DBP) has signed an agreement with Euroresearch Srl for the distribution of their selected products on the Scandinavian market. The sales of these products will be handled by DBP’s subsidiary Drugsson AB. The products, Biospray and Biopad, are medical devices and are used for the treatment of minor burns, skin irritation, wounds, bed sores, diaper- and incontinence rash, skin damage and abrasions, hemostat. Drugsson will market the products to both consumers (self-care) and healthcare, which means that the products have a broad potential market. As always,

BONESUPPORT™ LAUNCHING A NEW PRODUCT - BONIFY™ - US PRODUCT PORTFOLIO EXPANSION

Lund, Sweden, 08.00 CET, March 13, 2019 – BONESUPPORT™ , an emerging leader in orthobiologics for the management of bone voids, today announced the launch of BONIFY™, a demineralized bone matrix (DBM) product line, expanding the company’s product portfolio in the US market. BONIFY will be launched at the American Academy of Orthopedic Surgeons (AAOS) 2019 Annual Meeting in Las Vegas, NV, March 13-15, 2019.   BONIFY is a unique bone graft composed of 100 percent DBM that offers osteoinductive potential to aid in the bone healing process. BONIFY serves to complement the company’s

Essity publishes its Annual and Sustainability Report for 2018

Hygiene and health company Essity has today published its Annual and Sustainability Report for 2018, available at www.essity.com.“In 2018, we strengthened our brands through successful innovations, improved our product mix, implemented price increases and intensified efficiency improvements and restructuring measures. We took actions in all parts of the business to increase profitability and offset the negative impact on earnings of the significantly higher raw material and energy costs. The work to contribute to a sustainable and circular society was rewarded. We qualified for inclusion in

Partnerships at the core of Paulig’s coffee sourcing: Concrete measures taken to help coffee farmers adapt to climate change

Climate change is a major threat to the future availability of coffee, which is already clearly visible in the everyday life of farmers. Consumers are also worried about climatic change, and as much is evident in their attitudes. According to the survey carried out by Kantar TNS, 54% of respondents prefer to buy environmentally friendly coffee, and 74% of Finnish coffee-lovers think it is important that coffee farmers are given training in sustainable farming methods. Paulig has done systematic long-term work to promote the well-being of the environment throughout the whole supply

IRRAS evaluates a possible listing of the company’s share on Nasdaq Stockholm’s main market during 2019

Stockholm, March 13, 2019 – IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company, today announced the company plans to evaluate a possible relisting of its shares from Nasdaq First North Premier to Nasdaq Stockholm’s main market during 2019. IRRAS has engaged Carnegie Investment Bank as financial advisor to explore this potential relisting and to evaluate other strategic financial initiatives. A transition to Nasdaq’s main market in Sweden is part of the company’s business strategy to become a leading medical technology company and industry leader

Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula

Herantis Pharma Oyj: Manager’s Transactions - Pekka Simula Herantis Pharma PlcCompany release 13 March 2019 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Pekka Simula Position: Chief Executive Officer Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20190312213858_5 ____________________________________________ Transaction date: 2019-03-12 Venue not applicable

Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila

Herantis Pharma Oyj: Manager’s Transactions - Pekka Mattila Herantis Pharma PlcCompany release 13 March 2019 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Pekka Mattila Position: Member of the Board/Deputy member Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number: 743700W4CQVYAT3WKK38_20190312214606_7 ____________________________________________ Transaction date: 2019-03-12 Venue not

Herantis Pharma Oyj: Manager’s Transactions - Mats Heiman

Herantis Pharma Oyj: Manager’s Transactions - Mats Heiman Herantis Pharma PlcCompany release 13 March 2019 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Mats Heiman Position: Closely associated person (1):Person Discharging Managerial Responsibilities In Issuer Name: Ingrid Atteryd Heiman Position: Member of the Board Issuer: Herantis Pharma Oyj LEI: 743700W4CQVYAT3WKK38 Notification type: INITIAL NOTIFICATION Reference number:

Outotec to deliver sulfuric acid plant to Morocco

OUTOTEC OYJ PRESS RELEASE MARCH 13, 2019 AT 9:00 AM Outotec to deliver sulfuric acid plant to Morocco Outotec has signed a contract with the Moroccan OCP Group for the delivery of a sulfuric acid plant for fertilizer production. The approximately EUR 80 million order has been booked into Outotec's 2019 first quarter order intake. Outotec's delivery includes the engineering, procurement and construction of the plant, which is based on Outotec's sulfur burning system. The new acid plant will incorporate advanced proprietary technologies such as HEROS heat recovery system as well as a

Systemair AB Interim Report Q3 2018/19 - Growth still strong

Press Release, March 13, 2019 Third quarter November 2018 - January 2019 · Net sales increased by 13.8 percent to SEK 2,018 million (1,773). · Organic growth was 6.2 percent (4.0). · Operating profit (EBIT) totalled SEK 80 million (68). · The operating margin was 4.0 percent (3.8). · Profit after tax amounted to SEK 45 million (42). · Earnings per share totalled SEK 0.86 (0.80). · Cash flow from operating activities amounted to SEK 189 million (67). Roland Kasper, President and CEO, comments:"During the third quarter, growth was recorded at 13.8

Cereno Scientific expands its pipeline — signs agreement on acquisition of compound in pre-clinical phase

Cereno Scientific announced today that the company has signed an agreement with Emeriti Bio AB regarding the acquisition of the compound EB014. The compound has innovative properties and will expand Cereno Scientific’s portfolio in cardiovascular diseases.“After the positive results we received from the first clinical study with CS1 and an upcoming Phase II study planned, this is the right time to broaden our operations. The acquisition means we now have a portfolio of drug candidates with potential for several indications in cardiovascular diseases,” says Cereno Scientific CEO Sten R.

The new Planmeca Romexis® 6.0 highlights usability and streamlines workflows

Planmeca is proud to announce a renewed version of its groundbreaking all-in-one software, Planmeca Romexis®. The new version of the software introduces an improved user interface with even better usability as well as a wide selection of new tools and features. The Planmeca Romexis® 6.0 software solution provides versatile tools for all imaging needs, from efficient day-to-day imaging to advanced diagnosis and treatment planning. Version 6.0 features a modern look and feel that highlights usability. The easy navigation with fewer clicks and a customisable user interface streamlines the

CORRECTION: Pihlajalinna’s Annual Report for 2018 published

Pihlajalinna Plc       Stock Exchange Release   13 March 2019 at 08:00 This is a correction to Pihlajalinna Plc`s stock exchange release issued on March 12, 2019 at 17.00 EET regarding the publishing of Pihlajalinna´s Annual Report, Corporate Governance Statement and Statement of Non-Financial Information for 2018. The stock exchange release issued previously did not include all the attachments. Please find below the original stock exchange release with the correct attachments. Pihlajalinna’s Annual Report for 2018 published  Pihlajalinna's Annual Report for 2018 has been published

Caverion and Skanska to develop new building for the university hospital in Oulu, Finland

Caverion Finland Press release 13 March 2019 at 08:00 a.m. EETCaverion and Skanska to develop new building for the university hospital in Oulu, Finland   The Northern Ostrobothnia Hospital District has chosen Caverion and Skanska as its alliance partners for the first phase of the Future Hospital OYS 2030 project, concerning the development of the so-called B-building. [OYS] The project is implemented through an alliance model where the execution is preceded by a development stage. During this stage, the plans are developed in collaboration with alliance partners, hospital line

Clas Ohlson nine-month report 2018/19

Third quarter – 1 November 2018 to 31 January 2019 · Sales increased by 6% to 2,915 MSEK (2,746), organic sales up 4% and up 2% in comparable units · Online sales increased by 51% · Operating profit, including non-recurring costs, costs linked to the CO100+ action programme and the closure of the store network in the UK and Germany totalled 105 MSEK (349) · A non-recurring cost of 210 MSEK was charged to earnings as a result of the closure of the store network in the UK and Germany. The closure is expected to generate a positive earnings effect of approximately 75 MSEK, with

NEXT Biometrics and MK Group to Expedite Secure Authentication Solutions in Vietnam, South Africa and Brazil

Oslo, March 13, 2019 –NEXT Biometrics (Oslo Bors: NEXT), a global leader in fingerprint sensor technology, and secure authentication and smart card solutions provider MK Group have agreed to extend cooperation. Joint market and product development efforts will now also comprise identity and access management (IAM) applications as well as Public-Key-Infrastructure* (PKI)-based secure authentication solutions. NEXT Biometrics had announced a joint R&D program with MK Group for next generation biometric smart cards in November 2018. Close collaboration between both companies` technical and

SDRL - Launches Tender Offer for 12.0% Senior Secured Notes due 2025

Hamilton, Bermuda, March 12, 2019 - Seadrill Limited (the "Company") has commenced a cash tender offer for up to c.$311 million in aggregate principal amount of its 12.0% Senior Secured Notes due 2025 (the "Notes") pursuant to an offer to purchase, dated March 12, 2019.   The tender offer will expire at 11:59 p.m., New York City time, on April 8, 2019 (the "Expiration Time"). Tendered Notes may not be withdrawn after the Expiration Time.  Holders who validly tender and do not validly withdraw their Notes on or before the Expiration Time will be eligible to receive $1,070 per $1,000

SOTKAMO SILVER AB: NOTICE OF ANNUAL GENERAL MEETING IN SOTKAMO SILVER AKTIEBOLAG (PUBL)

Press release: Stockholm, March 12th, 2019 The shareholders of Sotkamo Silver Aktiebolag (publ) are invited to attend the Annual General Meeting (“AGM”) to be held on Thursday, April 11, 2019, at 10.00 am at Jernkontoret, Kungsträdgårdsgatan 10, in Stockholm, Sweden. Registration will open at 9.30 am AttendanceA shareholder wishing to attend the AGM must be registered as shareholder on Friday,April 5, 2019, in the shareholders register maintained by Euroclear Sweden AB. Notice of intention to attend the AGM can be made to the Company no later than on Monday, April 8 , 2019, in

Hoist Group Welcomes AP6 as New Co-Owner

Hoist Group Holding Intressenter AB (publ) (”Hoist Group” or the “Company”) is proud to announce the Sixth Swedish National Pension Fund (“AP6”) as a new equity investor, strengthening the Company in its ambition for further growth.Hoist Group is welcoming AP6 as a new shareholder alongside the main owner, the investment fund Accent Equity 2008, and the Company’s founder Malcolm Lindblom. AP6 is a specialist fund that is a part of the Swedish national pension system. It invests in unlisted companies, both directly and indirectly through funds, and has more than SEK 30 billion under

TODAY IS #1 IN KEY DEMO, BEST WIN IN 2 MONTHS

TODAY Wins 167 Weeks in Key Demo, Best Streak in 6 Years  TODAY Tops GMA in Total Viewers Monday and Tuesday, Comes Within Just 18K Viewers for the Week TODAY Is the Only Morning Show to Post Year-to-Year Growth in Total Viewers TODAY Shrinks Total Viewer Gap with GMA By a Giant 93% Vs. Year AgoNEW YORK – March 12, 2019 – NBC News’ TODAY was the number-one morning show last week topping ABC’s “Good Morning America” in the key A25-54 demo, marking its biggest win over GMA in eight weeks. TODAY has now won the key demo for 167 straight weeks, delivering its best streak in over six

There are no items matching the current filter
There are no more items matching the current filter
Back to top